| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |